Jinhai Medical Technology Limited (HKG:2225)

Jinhai Medical Technology Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	46.28	50.24	45.64	22.28	21.9
Revenue Growth (YoY)	-7.89%	10.07%	104.87%	1.75%	-2.56%
Cost of Revenue	39.09	38.76	33.62	12.16	14.17
Gross Profit	7.19	11.48	12.03	10.12	7.73
Selling, General & Admin	25.02	31.95	15.95	10.25	8.71
Operating Expenses	25.2	31.57	16.62	10.12	9.16
Operating Income	-18.01	-20.09	-4.59	-	-1.43
Interest Expense	-0.68	-0.77	-0.22	-0.09	-0.13
Interest & Investment Income	0.07	0.29	0.36	0.45	0.18
Currency Exchange Gain (Loss)	-0.28	0.28	-0.63	0.11	0.18
Other Non Operating Income (Expenses)	1.1	1.46	2.8	0.55	0.19
EBT Excluding Unusual Items	-17.8	-18.83	-2.29	1.03	-1.02
Gain (Loss) on Sale of Investments	0.5	0.23	-1.02	-0.89	-0.81
Gain (Loss) on Sale of Assets	0.01	0.02	-0.02	0.15	0.28
Asset Writedown	-	-	-	-	-0.08
Other Unusual Items	-	0.17	0.01	0.32	1.49
Pretax Income	-17.16	-18.23	-3.22	0.78	-0.06
Income Tax Expense	0.23	0.03	0.9	0.67	0.44
Earnings From Continuing Operations	-17.4	-18.26	-4.11	0.12	-0.5
Minority Interest in Earnings	0.32	0.29	0.97	0.35	0.25
Net Income	-17.08	-17.97	-3.14	0.47	-0.25
Net Income to Common	-17.08	-17.97	-3.14	0.47	-0.25
Shares Outstanding (Basic)	5,216	5,170	4,971	4,920	4,920
Shares Outstanding (Diluted)	5,216	5,170	4,971	4,920	4,920
Shares Change (YoY)	0.88%	4.00%	1.04%	-	-
EPS (Basic)	-0.00	-0.00	-0.00	0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	0.00	-0.00
Free Cash Flow	-5.66	-4.26	-3.15	3.06	2.73
Free Cash Flow Per Share	-0.00	-0.00	-0.00	0.00	0.00
Gross Margin	15.53%	22.84%	26.35%	45.40%	35.29%
Operating Margin	-38.92%	-39.98%	-10.06%	-	-6.55%
Profit Margin	-36.91%	-35.76%	-6.88%	2.10%	-1.12%
Free Cash Flow Margin	-12.23%	-8.49%	-6.89%	13.75%	12.48%
EBITDA	-14.39	-16.29	-1.33	3.57	2.33
EBITDA Margin	-31.10%	-32.42%	-2.90%	16.03%	10.63%
D&A For EBITDA	3.62	3.8	3.27	3.57	3.76
EBIT	-18.01	-20.09	-4.59	-	-1.43
EBIT Margin	-38.92%	-39.98%	-10.06%	-	-6.55%
Effective Tax Rate	-	-	-	85.20%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.